DexCom
DXCM
#788
Rank
HK$231.87 B
Marketcap
HK$621.72
Share price
-1.08%
Change (1 day)
33.68%
Change (1 year)

EPS for DexCom (DXCM)

EPS in 2026 (TTM): HK$20.27

According to DexCom's latest financial reports the company's current EPS (TTM) is HK$20.30. In 2025 the company made an earnings per share (EPS) of HK$16.85 an increase over its 2024 EPS that were of HK$11.52.

EPS history for DexCom from 2014 to 2026

Annual EPS

Year EPS Change
2026 (TTM)HK$20.2720.28%
2025HK$16.8546.26%
2024HK$11.524.26%
2023HK$11.0560.23%
2022HK$6.9066.82%
2021HK$4.13
2019HK$2.14-175.69%
2018-HK$2.82144.07%
2017-HK$1.16-24.36%
2016-HK$1.536.85%
2015-HK$1.43143.33%
2014-HK$0.59

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
HK$52.36 157.91%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
HK$21.19 4.40%๐Ÿ‡บ๐Ÿ‡ธ USA
Medtronic
MDT
HK$31.98 57.53%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Becton Dickinson
BDX
HK$28.22 39.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Edwards Lifesciences
EW
HK$13.87-31.66%๐Ÿ‡บ๐Ÿ‡ธ USA
Tandem Diabetes Care
TNDM
-HK$7.29-135.91%๐Ÿ‡บ๐Ÿ‡ธ USA
QuidelOrtho
QDEL
-HK$42.40-308.88%๐Ÿ‡บ๐Ÿ‡ธ USA
West Pharmaceutical Services
WST
HK$70.31 246.33%๐Ÿ‡บ๐Ÿ‡ธ USA